Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Gorilla and King Portfolio Candidates -- Ignore unavailable to you. Want to Upgrade?

To: Lizzie Tudor who wrote (52591)	8/29/2002 9:11:15 PM
From: chaz	Read Replies (1) \| Respond to of 54805

Thank you, Lizzie... The remaining product areas you mention as remaining as of present date don't seem particularly primate-like, with the possible exception of Remedy. I don't know enough about the other two products, but they strike me as easily duplicated applications that would belong in a royalty line. To place them correctly in a royalty line, we'd need to know competitors, market shares, etc. You say they bought Remedy primarily for the database. I don't quite understand that. Was there no product there, no IP? Seems very strange. Chaz